Ginkgo Bioworks Holdings (DNA) Other financing activities (2020 - 2024)
Ginkgo Bioworks Holdings' (DNA) quarterly Other financing activities came in at -$80000.0 in Q4 2024, down 106.76% YoY from $1.2 million in Q1 2024, and down 671.43% on a QoQ basis from $14000.0 in Q2 2024.
Ginkgo Bioworks Holdings (DNA) Other financing activities (2020 - 2024) Analysis & Trends
Ginkgo Bioworks Holdings (DNA) has 5 years of Other financing activities data on file, last reported at -$80000.0 in Q4 2024.
- Quarterly Other financing activities fell 106.76% year-over-year to -$80000.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was -$80000.0 (down 106.31% YoY) and the FY2024 annual result came in at $4000.0, down 99.31% from the prior year.
- Other financing activities eased to -$80000.0 in Q4 2024, from $14000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $100.3 million in Q4 2022 to a low of -$980000.0 in Q2 2022.
- A 5-year average of $6.3 million and a median of $12000.0 in 2021 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 79500.0% in 2022, down 8266.67% in 2022.
- Tracing DNA's Other financing activities over 5 years: stood at $7000.0 in 2020, then soared by 1700.0% to $126000.0 in 2021, then soared by 79500.0% to $100.3 million in 2022, then slumped by 98.82% to $1.2 million in 2023, then sank by 106.76% to -$80000.0 in 2024.
- The last three Other financing activities figures came in at -$80000.0 (Q4 2024), $14000.0 (Q2 2024), and $70000.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ginkgo Bioworks Holdings | 432.60 Mn | 348.06 Mn | 18.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -80,000.00 |
| Dec 31, 2024 | -80,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Mar 31, 2024 | 70,000.00 |
| Mar 31, 2024 | 70,000.00 |
| Dec 31, 2023 | 1.18 Mn |
| Dec 31, 2023 | 1.18 Mn |
| Sep 30, 2023 | -1,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -615,000.00 |
| Jun 30, 2023 | -615,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Dec 31, 2022 | 100.30 Mn |
| Dec 31, 2022 | 100.30 Mn |
| Sep 30, 2022 | -88,000.00 |
| Sep 30, 2022 | -88,000.00 |
| Jun 30, 2022 | -980,000.00 |
| Jun 30, 2022 | -980,000.00 |